Quantification of dolichol in the human lens with different types of cataracts.
OBJECTIVE
To quantify and characterize dolichol species in cataractous and clear human lenses.


METHODS
Whole lenses were collected from cadaver eyeballs from the C.H. Nagri Eye Bank and Red Cross Society Eye Bank (Ahmedabad, India). Cataractous nuclei were collected after extracapsular cataract extraction (ECCE). Wet weight for all the lenses was taken and were stored at -50 degrees C until used. Dolichol was extracted using a standard protocol and then analyzed using High Performance Liquid Chromatography (HPLC) on a 4.6 mmx60 mm Hypersil-Octadecylsilane (ODS; 3 microm) reversed phase column using a Waters dual pump apparatus, a Waters gradient programmer, and an ultraviolet (UV) detector set at 210 nm. Dolichol 13 was used as an internal standard, and dolichol mixture from the liver was used as an external qualitative standard.


RESULTS
The highest dolichol concentration was found in nuclear cataract (2.54+/-0.6 microg) followed by posterior subcapsular cataract (1.4+/-0.35 microg), and the lowest levels were observed in cortical cataract (0.37+/-0.06 microg). The level of dolichol concentration in cataractous lenses was statistically significantly higher than the levels in clear lenses (1.0+/-04.3 microg; p<0.01).


CONCLUSIONS
The dolichol concentration was significantly higher in lenses with nuclear cataract. A significant difference in dolichol concentration was observed between the different types of cataract. It suggests that dolichol and other isoprenoids may be associated with cataractogenesis.
Gajjar
Devarshi
D
Iladevi Cataract and IOL Research Centre, Ahmedabad, India.
Jozwiak
Adam
A
Swiezewska
Ewa
E
Alapure
Bhagwat
B
Parmar
Trilok
T
Johar
Kaid
K
Vasavada
Abhay R
AR
D000368:Aged; D002386:Cataract / Q000378:metabolism*; D002851:Chromatography, High Pressure Liquid; D004286:Dolichols / Q000032:analysis*; D006801:Humans; D007908:Lens, Crystalline / Q000737:chemistry*; D008099:Liver / Q000378:metabolism; D008875:Middle Aged; D012015:Reference Standards
D004286:Dolichols
Prog Lipid Res. 1985;24(4):269-309
2819898
Biogerontology. 2003;4(6):379-85
14739709
Invest Ophthalmol Vis Sci. 1998 Jun;39(7):1276-80
9620091
J Biol Chem. 1996 Apr 19;271(16):9560-6
8621629
Lipids. 2003 Sep;38(9):981-90
14584606
J Cell Sci. 1992 Dec;103 ( Pt 4):1065-72
1487489
Lipids. 1989 Jul;24(7):579-84
2779364
FASEB J. 1995 Sep;9(12):1173-82
7672510
Curr Eye Res. 1997 Jun;16(6):527-33
9192160
Prog Lipid Res. 2005 Jul;44(4):235-58
16019076
Invest Ophthalmol Vis Sci. 1994 Feb;35(2):363-6
8112982
Br J Exp Pathol. 1989 Feb;70(1):83-92
2538136
Mol Vis. 2005 Aug 10;11:594-602
16110301
Surv Ophthalmol. 1996 Jan-Feb;40(4):320-37
8658343
J Gerontol A Biol Sci Med Sci. 2005 Jan;60(1):39-43
15741281
Biochim Biophys Acta. 1997 Jul 12;1347(1):93-100
9233691
Biochim Biophys Acta. 1989 Apr 3;1002(2):218-24
2930770
Am J Med Genet. 1995 Jul 3;57(3):493
7677158
J Biol Chem. 2006 Oct 20;281(42):31696-704
16923818
Biogerontology. 2003;4(6):337-9
14756125
Free Radic Res. 2007 Nov;41(11):1283-8
17957544
Arch Ophthalmol. 1993 Jun;111(6):831-6
8512486
J Alzheimers Dis. 2004 Apr;6(2):129-35
15096696
J Nutr. 1997 May;127(5):668-74
9164984
J Neurochem. 2005 Feb;92(4):990-5
15686500
Pediatrics. 1993 May;91(5):915-21
8386351
Cancer Res. 1991 Jul 15;51(14):3774-80
2065332
Traffic. 2003 Sep;4(9):607-17
12911815
J Lipid Res. 1988 Dec;29(12):1651-62
3244016
Biogerontology. 2003;4(6):365-70
14739707
Invest Ophthalmol Vis Sci. 2000 Jul;41(8):2255-61
10892870
Glycobiology. 2005 Apr;15(4):347-59
15563715
Biochim Biophys Acta. 1983 May 16;751(3):355-68
6849949
Biochim Biophys Acta. 1984 Dec 6;796(3):294-303
6548933
Exp Eye Res. 2002 Apr;74(4):503-11
12076094
J Nutr. 1999 Apr;129(4):804-13
10203554
Arch Ophthalmol. 1981 Nov;99(11):2000-6
7295150
Clin Exp Ophthalmol. 2001 Jun;29(3):111-5
11446447
Invest Ophthalmol Vis Sci. 2005 May;46(5):1682-9
15851569
Biochem J. 1988 Apr 1;251(1):1-9
3291859
Biochim Biophys Acta. 1999 Dec 6;1473(1):4-8
10580125
J Ocul Pharmacol Ther. 2000 Apr;16(2):121-35
10803423
Invest Ophthalmol Vis Sci. 1979 May;18(5):462-7
437948